SCHEMBL20735987

SCHEMBL20735987

CCn1c(-c2cccc(-c3cc4c(c5ccccc35)-c3c(ccc5cc(Cn6c(-c7cccc(-c8cc9c(c%10ccccc8%10)-c8c(ccc%10ccccc8%10)C98c9ccccc9-c9ccccc98)c7)nc7ccccc76)ccc35)C43c4ccccc4-c4ccccc43)c2)nc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.43
TP53 P04637 4/20 0.43
KDM4E B2RXH2 6/20 0.40
LMNA P02545 3/20 0.39
GAA P10253 1/20 0.38
ALDH1A1 P00352 4/20 0.37
PDE6D O43924 1/20 0.37
ALDH2 P05091 1/20 0.37
ALDH3A1 P30838 1/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 2/20 0.36
HTT P42858 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CNR2 P34972 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GRM2 Q14416 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27250511 0.93 KDM4E (0.41) MAPTTP53KDM4ELMNAGAA
SCHEMBL20737001 0.87 MAPT (0.45) MAPTTP53KDM4ELMNAGAA
SCHEMBL27250512 0.86 MAPT (0.50) MAPTTP53KDM4ELMNAGAA
SCHEMBL20736424 0.86 KDM4E (0.47) MAPTTP53KDM4ELMNAGAA
SCHEMBL20737697 0.83 KDM4E (0.40) MAPTTP53KDM4ELMNAGAA
SCHEMBL20737240 0.82 KDM4E (0.41) MAPTTP53KDM4ELMNAGAA
SCHEMBL27250387 0.82 MAPT (0.43) MAPTTP53KDM4ELMNAGAA
SCHEMBL20735986 0.81 HDAC1 (0.37) MAPTTP53LMNAGAAALDH1A1
SCHEMBL27250510 0.81 MEN1 (0.39) MAPTTP53KDM4ELMNAGAA
SCHEMBL27250570 0.81 KDM4E (0.41) MAPTTP53KDM4ELMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 MAPT 1713/4885TP53 3684/4885KDM4E 2169/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 MAPT 1713/4885TP53 3684/4885KDM4E 2169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.